EPS exerts its anti-inflammatory effects by downregulating the expression of VEGF in tumor cells, upregulating the expression of the anti-angiogenic factor tissue inhibitor of metalloproteinases-3 (TIMP-3) [109], downregulating pro-inflammatory factors, and upregulating anti-inflammatory factors [110]. Here, VEGFA is linked to neoplasm.